aztreonam has been researched along with Endomyometritis in 4 studies
Aztreonam: A monocyclic beta-lactam antibiotic originally isolated from Chromobacterium violaceum. It is resistant to beta-lactamases and is used in gram-negative infections, especially of the meninges, bladder, and kidneys. It may cause a superinfection with gram-positive organisms.
aztreonam : A synthetic monocyclic beta-lactam antibiotic (monobactam), used primarily to treat infections caused by Gram-negative bacteria. It inhibits mucopeptide synthesis in the bacterial cell wall, thereby blocking peptidoglycan crosslinking.
Endomyometritis: Inflammation of both the ENDOMETRIUM and the MYOMETRIUM, usually caused by infections after a CESAREAN SECTION.
Excerpt | Relevance | Reference |
---|---|---|
"Sixty-two patients who had postpartum endometritis were treated with clindamycin in combination with either aztreonam or the aminoglycoside gentamicin." | 9.06 | Comparison trial of clindamycin with aztreonam or gentamicin in the treatment of postpartum endometritis. ( Bollinger, M; Greenberg, RN; Ojile, JM; Reilly, PM; Weinandt, WJ; Wilson, KM, 1987) |
"5 mg/kg intravenously every eight hours), each with clindamycin (600 mg intravenously every six hours), was performed in 119 patients with endometritis after cesarean section." | 9.05 | Aztreonam versus gentamicin, each with clindamycin, in the treatment of endometritis. ( Blanco, JD; Gibbs, RS; Lipscomb, KA; St Clair, PJ, 1985) |
"Sixty-two patients who had postpartum endometritis were treated with clindamycin in combination with either aztreonam or the aminoglycoside gentamicin." | 5.06 | Comparison trial of clindamycin with aztreonam or gentamicin in the treatment of postpartum endometritis. ( Bollinger, M; Greenberg, RN; Ojile, JM; Reilly, PM; Weinandt, WJ; Wilson, KM, 1987) |
"5 mg/kg intravenously every eight hours), each with clindamycin (600 mg intravenously every six hours), was performed in 119 patients with endometritis after cesarean section." | 5.05 | Aztreonam versus gentamicin, each with clindamycin, in the treatment of endometritis. ( Blanco, JD; Gibbs, RS; Lipscomb, KA; St Clair, PJ, 1985) |
"Endomyometritis is the most common complication associated with cesarean delivery." | 3.76 | Pathophysiology and management of postcesarean endomyometritis. ( Duff, P, 1986) |
"Aztreonam, a new monobactam antibiotic with specific gram-negative aerobic activity, was used in combination with clindamycin in the treatment of 40 women with pelvic infection, including post-partum endometritis, pelvic inflammatory disease, and post-hysterectomy pelvic cellulitis." | 3.67 | Aztreonam plus clindamycin as therapy for pelvic infections in women. ( Aldridge, KE; Cole, C; Crapanzano, JC; Pastorek, JG, 1985) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Greenberg, RN | 1 |
Reilly, PM | 1 |
Weinandt, WJ | 1 |
Wilson, KM | 1 |
Bollinger, M | 1 |
Ojile, JM | 1 |
Duff, P | 1 |
Gibbs, RS | 1 |
Blanco, JD | 1 |
Lipscomb, KA | 1 |
St Clair, PJ | 1 |
Pastorek, JG | 1 |
Cole, C | 1 |
Aldridge, KE | 1 |
Crapanzano, JC | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Treatment Utility of Postpartum Antibiotics in Chorioamnionitis[NCT01585129] | Phase 4 | 80 participants (Actual) | Interventional | 2010-09-30 | Terminated (stopped due to Futility in patient enrollment) | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
This is the duration of hospital stay (in days) after their cesarean delivery. (NCT01585129)
Timeframe: Up to 7 Days
Intervention | days (Mean) |
---|---|
Postpartum Antibiotics | 4 |
No Postpartum Antibiotics | 4 |
Endometritis is defined as uterine infection and is diagnosed by maternal temp > 38.0C on two occasions over a 4 hour period or any temp > 39.0C after delivery > 12 hours after delivery. Endometritis will be managed per currently accepted endometritis protocol - (Amp 2 gQ6, Gentamicin 5 mg/kg q24, Clindamycin 900 mg q8). (NCT01585129)
Timeframe: 7 days post-partum
Intervention | Participants (Count of Participants) |
---|---|
Postpartum Antibiotics | 4 |
No Postpartum Antibiotics | 3 |
Infection related complications will include common complications attributed to infections there are not the primary outcome (endometritis). This will include infections of the wound and pelvic abscesses. (NCT01585129)
Timeframe: 7 days post-partum
Intervention | Participants (Count of Participants) |
---|---|
Postpartum Antibiotics | 7 |
No Postpartum Antibiotics | 2 |
1 review available for aztreonam and Endomyometritis
Article | Year |
---|---|
Pathophysiology and management of postcesarean endomyometritis.
Topics: Adult; Anti-Bacterial Agents; Aztreonam; Bacterial Infections; Cephalosporins; Cesarean Section; Cli | 1986 |
3 trials available for aztreonam and Endomyometritis
Article | Year |
---|---|
Comparison trial of clindamycin with aztreonam or gentamicin in the treatment of postpartum endometritis.
Topics: Adolescent; Adult; Aztreonam; Clindamycin; Clinical Trials as Topic; Drug Therapy, Combination; Endo | 1987 |
Pathophysiology and management of postcesarean endomyometritis.
Topics: Adult; Anti-Bacterial Agents; Aztreonam; Bacterial Infections; Cephalosporins; Cesarean Section; Cli | 1986 |
Aztreonam versus gentamicin, each with clindamycin, in the treatment of endometritis.
Topics: Adult; Anti-Bacterial Agents; Aztreonam; Cesarean Section; Clindamycin; Clinical Trials as Topic; Dr | 1985 |
1 other study available for aztreonam and Endomyometritis
Article | Year |
---|---|
Aztreonam plus clindamycin as therapy for pelvic infections in women.
Topics: Adult; Anti-Bacterial Agents; Aztreonam; Bacterial Infections; Clindamycin; Drug Evaluation; Drug Th | 1985 |